- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
June 29th, 2010
Venture capitalists and their limited partners have long bemoaned lackluster returns and the lengthening time until exits for portfolio companies. Publicly held venture firm Harris & Harris Group has gotten tired of waiting, and said it plans to invest more in public companies in a bid to make faster returns.
Since 2002, Harris & Harris has focused on backing companies with products based on nanotechnology or microsystems. Its private-company portfolio includes Mersana Therapeutics Inc., which develops cancer therapies based on its biodegradable polymer technology, and Solazyme Inc., which uses algae to produce clean fuels, chemicals, foods and health-science products.
|Related News Press|
News and information
Breaking cell barriers with retractable protein nanoneedles: Adapting a bacterial structure, Wyss Institute researchers develop protein actuators that can mechanically puncture cells February 12th, 2016
Properties of Polymeric Nanofibers Optimized to Treat Damaged Body Tissues February 12th, 2016
PEN Inc. Announces 1-for-180 Reverse Stock Split January 27th, 2016
Arrowhead to Webcast Fiscal 2015 Year End Results December 7th, 2015
Haydale Announce Year End Results November 3rd, 2015
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015